» Articles » PMID: 36457023

Are Chemical Compounds in Medical Mushrooms Potent Against Colorectal Cancer Carcinogenesis and Antimicrobial Growth?

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2022 Dec 2
PMID 36457023
Authors
Affiliations
Soon will be listed here.
Abstract

After cardiovascular diseases, cancer is the second main cause of death globally. Mushrooms have been demonstrated to contain amalgamation with properties capable of inhibiting carcinogenesis and microbial growth, principally secondary metabolites such as quinolones, steroids, terpenes, anthraquinones, and benzoic acid derivatives among others. This study aimed to substantiate their potency concerning colon cancer carcinogenesis and antimicrobial growth. A systematic search of important literature was performed considering all the articles published until April 2022. Screening was performed by searching the BMC Springer, Elsevier, Embase, Web of Science, Ovid, and MEDLINE databases. In addition, Google Scholar was used to supplement information. Titles and abstracts that matched the established criteria were selected for full-text article scrutiny and subsequently used in the updated present review. Bioactive compounds present in medicinal mushrooms such as ascorbic acid, organic acids, flavonoids, polysaccharides, glycosides, phenols, linoleic acid, grifolin, and tocopherols among other compounds play a key role in suppressing the proliferation of cancerous cells and selectively act as antibacterial and antifungal agents. These metabolites actively scavenge oxygen free radicals, hydroxyl radicals, and nitrite radicals that would otherwise increase the risks of the growth and development of cancerous cells. Mushrooms' bioactive compounds and metabolites actively inhibit nuclear factor-kappa activation, protein kinase B processes, and ultimately the expression of Cyclooxygenases 2 in cancerous cells. Medicinal mushrooms should be considered as alternative natural chemo-preventive agents in the global fight against colon cancer and the evolution of drug-resistant pathogenic microorganisms, as they exhibit robust potency. They have not been reported to exhibit adverse harmful effects compared to synthetic chemotherapies, yet they have been reported to demonstrate significant beneficial effects.

Citing Articles

evaluation of potential breast cancer receptor antagonists from GC-MS and HPLC identified compounds in extracts.

Effiong M, Bella-Omunagbe M, Afolabi I, Chinedu S RSC Adv. 2024; 14(33):23744-23771.

PMID: 39131188 PMC: 11310660. DOI: 10.1039/d4ra03832k.


In Vitro Inhibition of Colorectal Cancer Gene Targets by L. Methanolic Extracts: A Focus on Specific Genome Regulation.

Macharia J, Pande D, Zand A, Budan F, Kaposztas Z, Kovesdi O Nutrients. 2024; 16(8).

PMID: 38674831 PMC: 11054881. DOI: 10.3390/nu16081140.


Quercetin-induced pyroptosis in colon cancer through NEK7-mediated NLRP3 inflammasome-GSDMD signaling pathway activation.

Feng S, Zhao B, Zhan X, Li R, Yang Q, Wang S Am J Cancer Res. 2024; 14(3):934-958.

PMID: 38590424 PMC: 10998754. DOI: 10.62347/MKAN3550.


The Impact of Palliative Care on Mitigating Pain and Its Associated Effects in Determining Quality of Life among Colon Cancer Outpatients.

Macharia J, Raposa B, Sipos D, Melczer C, Toth Z, Kaposztas Z Healthcare (Basel). 2023; 11(22).

PMID: 37998446 PMC: 10671794. DOI: 10.3390/healthcare11222954.


Medicinal Characteristics of L. in Colorectal Cancer Management.

Macharia J, Kaposztas Z, Bence R Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513827 PMC: 10384768. DOI: 10.3390/ph16070915.


References
1.
Niedzwiecki A, Roomi M, Kalinovsky T, Rath M . Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer. Cancer Metastasis Rev. 2010; 29(3):529-42. PMC: 2933847. DOI: 10.1007/s10555-010-9244-1. View

2.
Singletary K, Milner J . Diet, autophagy, and cancer: a review. Cancer Epidemiol Biomarkers Prev. 2008; 17(7):1596-610. DOI: 10.1158/1055-9965.EPI-07-2917. View

3.
Jaworska G, Pogon K, Skrzypczak A, Bernas E . Composition and antioxidant properties of wild mushrooms Boletus edulis and Xerocomus badius prepared for consumption. J Food Sci Technol. 2015; 52(12):7944-53. PMC: 4648917. DOI: 10.1007/s13197-015-1933-x. View

4.
Yap H, Muria-Gonzalez M, Kong B, Stubbs K, Tan C, Ng S . Heterologous expression of cytotoxic sesquiterpenoids from the medicinal mushroom Lignosus rhinocerotis in yeast. Microb Cell Fact. 2017; 16(1):103. PMC: 5468996. DOI: 10.1186/s12934-017-0713-x. View

5.
Matijasevic D, Pantic M, Raskovic B, Pavlovic V, Duvnjak D, Sknepnek A . The Antibacterial Activity of Coriolus versicolor Methanol Extract and Its Effect on Ultrastructural Changes of Staphylococcus aureus and Salmonella Enteritidis. Front Microbiol. 2016; 7:1226. PMC: 4972825. DOI: 10.3389/fmicb.2016.01226. View